small molecule therapeutic for tablet formulation (Beijing Molecule Science & Technology)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesmall molecule therapeutic for tablet formulation (Beijing Molecule Science & Technology)
Drug Alias Nameaisuonaban mesylate (Beijing Molecule Science & Technology)aisuonabant mesylate (Beijing Molecule Science & Technology)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Molecule Science And Technology Limited Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Molecule Science And Technology Limited Company
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A